In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ademetionine 1,4-Butanedisulfonate Drug Master File in Korea (Ademetionine 1,4-Butanedisulfonate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ademetionine 1,4-Butanedisulfonate. The MFDS reviews the Ademetionine 1,4-Butanedisulfonate KDMF as part of the drug registration process and uses the information provided in the Ademetionine 1,4-Butanedisulfonate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ademetionine 1,4-Butanedisulfonate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ademetionine 1,4-Butanedisulfonate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ademetionine 1,4-Butanedisulfonate suppliers with KDMF on PharmaCompass.